Antibodies Inc. Is Fastest Growing Segment Fueling The Growth Of Cancer Diagnostics Market


https://www.coherentmarketinsights.com/market-insight/cancer-diagnostics-market-4029
Cancer Diagnostics Market 


The global Cancer Diagnostics Market is estimated to be valued at US$ 59.1 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview

Cancer diagnostics includes products and techniques used to diagnose different types of cancers in the human body. Early detection plays a crucial role in cancer management and monitoring disease progression and response to therapy. Cancer diagnostics helps in diagnosing cancer at early stages and provides better treatment options to patients.

Market key trends

One of the key trends in cancer diagnostics market is the increasing adoption of monoclonal antibodies. Monoclonal antibodies bind to specific epitopes on cancer cells and help in early detection of various cancers including breast cancer, lung cancer and colorectal cancer. They play a major role in cancer staging, prognosis and guiding treatment decisions. Development of precision antibodies with high selectivity and affinity provides accurate cancer detection. Advancements in antibody engineering have enabled development of novel antibodies for blood-based and imaging-based liquid biopsy tests. Growing R&D in this area is expected to drive the market during the forecast period.

Segment Analysis

Content: The cancer diagnostics market is segmented into tumor type, technology, application, and end user. The tumor type segment is further divided into breast cancer, lung cancer, colorectal cancer, melanoma, and others. The breast cancer segment currently dominates the market due to the rising prevalence of breast cancer globally.

Key Takeaways

Market size: The global Cancer Diagnostics Market Size is expected to witness high growth, exhibiting CAGR of 7.1% over the forecast period, due to increasing prevalence of cancer and launch of advanced diagnostic technologies.

Regional analysis: North America dominates the global cancer diagnostics market currently due to presence of advanced healthcare infrastructure and increasing healthcare expenditure in the region. Asia Pacific is expected to be the fastest growing market owing to rising healthcare standards and increasing focus of key players.

Key players: Key players operating in the cancer diagnostics market are Myriad Genetics, Inc., F. Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc., BPS Bioscience, Inc. Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Exagen Inc. Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, Abbott Laboratories, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Aurora Imaging Technologies, Inc., and Quest Diagnostics.

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more